MedTrace Logo

RATME Vs LATME in Middle and Low Rectal Cancer

NCT06105203 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1026

Last updated 2025-02-19

No results posted yet for this study

Summary

This is a multicenter, superior, randomized controlled trial designed to compare Robotic-assisted total mesorectal excision (RATME) and laparoscopic-assisted total mesorectal excision (LATME) for middle and low rectal cancer. The primary endpoint is the incidence of intersphincteric resection (ISR). The secondary outcomes are coloanal anastomosis (CAA), conversion to open, conversion to transanal TME (TaTME), incidence of abdominoperineal resection (APR), postoperative morbidity and mortality within 30 days after surgery, pathological outcomes, long-term survival outcomes, functional outcomes, and quality of life.

Conditions

  • Total Mesorectal Excision
  • Rectal Neoplasms
  • Robotic Surgical Procedures
  • Laparoscopy

Interventions

PROCEDURE

Robotic-assisted total mesorectal excision

TME will be performed with the assistance of robot in rectal cancer

PROCEDURE

laparoscopic-assisted total mesorectal excision

TME will be performed with the assistance of laparoscopy in rectal cancer

Sponsors & Collaborators

  • Jilin Provincial Tumor Hospital

    collaborator OTHER

  • Daping Hospital and the Research Institute of Surgery of the Third Military Medical University

    collaborator OTHER

  • The Second Affiliated Hospital of Dalian Medical University

    collaborator OTHER

  • The Second Affiliated Hospital of Harbin Medical University

    collaborator OTHER

  • The First Hospital of Jilin University

    lead OTHER

Principal Investigators

  • Quan Wang, Ph.D. · The First Hospital of Jilin University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-11-01
Primary Completion
2028-01-31
Completion
2031-01-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06105203 on ClinicalTrials.gov